Dr Sharon Fruh, of the University of South Alabama, discusses obesity prevention strategies clinicians can use with parents in guiding them to promote healthy habits at home, including family meals, better sleep schedules, decreased screen time, and improved communication between family members.

In part 2 of this podcast, Dr Eileen O'Grady talks about realistic goal-setting for weight loss, how to spark motivation in your patients, and overcoming setbacks.

In part 1 of this podcast, Dr Eileen O'Grady discusses strategies she uses in her own practice that have helped her patients successfully lose weight, and how the cycle of change impacts weight loss.

Dr David Cennimo, of Rutgers New Jersey Medical School, discusses the current state of the US measles outbreak and overviews causes, symptoms, treatment, and the importance of vaccination.

Dr Stephanie Chung, from the National Institutes of Health, answers our questions about her research on a 1-hour glucose tolerance test for diagnosing diabetes in teenaged girls.

In part 3 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, gives strategies that may help prevent clinical inertia and improve diabetes management on patient and practitioner levels.

Dr David Flanigan from The Ohio State University Wexner Medical Center discusses a new knee device designed to treat osteoarthritis symptoms, how it could potentially help patients prevent or delay knee replacements, and more.

Dr Daniel Einhorn from the Scripps Whittier Diabetes Institute talks about how the latest diabetes guidelines impacts treatment for patients with comorbid cardiovascular disease.

Dr David Llewellyn from the University of Exeter Medical School answers our questions about his research on dementia misclassification when using brief cognitive assessments.

Dr Molly Jeffery, of the Mayo Clinic in Minnesota, details a practice that may be undermining patients’ decision-making regarding whether or not to visit emergency care, and discusses her research on a potential solution.

In part 2 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.

Dr Maria Suarez-Almazor discusses the prevalence of patient nonadherence to medications in a rheumatology setting, how a provider can improve their patient/provider relationship, and more.

Dr Stephen Kopecky from Mayo Clinic talks about nonpharmacologic and pharmacologic options for preventing atrial fibrillation.

Many patients already struggle to afford their necessary prescriptions, but the prices of hundreds of drugs — including some generics — are set to rise even higher this year. In a podcast interview with Consultant360, Dr David Nash, founding dean of the Jefferson College of Population Health and chair of the 19th Population Health Colloquium, d ...…

Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.

In part 1 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’ diabetes.

Dr Wendy Marder discusses the impact of telemedicine in the practice of rheumatology, how it will benefit patients with long-term rheumatologic disorders, and more.

Confirmatory testing for food allergies and epinephrine carriage are more important than ever, now that new findings reveal greater numbers of US adults reporting food allergies. In this podcast, Dr Ruchi S. Gupta, of the Northwestern University Feinberg School of Medicine, and Christopher Warren, of the Keck School of Medicine of USC, discuss ...…

In this 3-minute mini-podcast, Dr James Matera from CentraState Medical Center discusses how the 2017 ACC/AHA hypertension guideline has changed the landscape when it comes to managing comorbid cardiovascular disease, diabetes, and kidney disease.

Dr Laxmi Mehta, from Ohio State University, talks about the CVD prevention methods that are on the horizon for women.

Dr Laxmi Mehta, from Ohio State University, talks about coronary disease treatments for pregnant women, gives an example of a challenging patient case, and elaborates on the role of statins in the treatment plan for pregnant women.

Dr Laxmi Mehta, from Ohio State University, talks about how treatment options differ between men and women who present with myocardial infarction and how to prevent a subsequent infarction.

Dr Nathan Bryan, from Baylor College of Medicine, talks about the importance of nitric oxide in diagnosing and treating pulmonary conditions, including asthma.

In the final installment of this podcast series, Dr Robert S. Laitman from Bronx Westchester Medical Group and SARDAA discusses suicidality in patients with schizophrenia compared with the general population. He also outlines steps clinicians can take to help prevent suicides in their patients.

Dr Vikas Majithia discusses the new psoriatic arthritis guidelines, how physicians can apply them to practice, managing patient manifestations, and more.

Dr Arnold Wald discusses current treatments for IBS and IBS-D, the importance of a strong patient-provider relationship to properly manage the condition, and more.

Dr James Matera, of CentraState Medical Center, explains the interaction between diabetes, cardiovascular disease, and kidney disease, and how the presence of one or more of these conditions can complicate treatment outcomes.

Dr Kim Carmichael, professor of medicine at the Washington University School of Medicine in St. Louis and series editor of Consultant360’s Diabetes Q&As, discusses his latest column, “What Do You Need to Know About Diabetic Gastroparesis?”

In our previous podcast with Dr John Mastronarde, he told us all about the controversy around asthma-COPD overlap. In this soundbite, he outlines the top 3 takeaways for pulmonologists.

Dr John Mastronarde, from the Oregon Clinic's Asthma Center, talks to us about the controversy around asthma-COPD overlap, the diagnostic challenges associated with overlap, and how to treat patients who do not fall into one box or the other.

Dr Marcel Daadi, from Texas Biomedical Research Institute, talks about his life-long research into dopaminergic neurons for treating Parkinson disease and whether it is possible to replenish dopamine loss in the brain.

Dr Bruce Rothschild discusses the importance of monitoring janus kinase inhibitor use in rheumatic diseases, the role of antiphospholipid antibodies for addressing safety, and more.

Dr Julie Khlevner discusses the current management of upper gut motility disorders in children, the potential for delay in diagnosis, and more.

Dr Christina Ha from Cedars-Sinai Medical Center discusses the management of IBD in the elderly, potential for undertreatment, balancing medication interactions, and more.

Dr Gregory Poland, from Mayo Clinic, Rochester, speaks about his 3 takeaways for what you need to know about vaccination in the elderly population.

Dr Gregory Poland, from Mayo Clinic, Rochester, speaks about zoster vaccination in older adults, how it will affect them later on, and the contraindications for the vaccine.

Dr Gregory Poland, from Mayo Clinic, Rochester, speaks about influenza vaccination in the elderly, how the approval of baloxavir marboxil will impact that patient population, and more.

Dr Monica Kraft, from the Asthma and Airway Disease Research Center, gives an overview of nocturnal asthma as well as walks through a patient case example of diagnosing and treating nocturnal asthma.

Dr Monica Kraft, from the Asthma and Airway Disease Research Center, gives an overview of eosinophilic asthma as well as walks through a patient case example of diagnosing and treating eosinophilic asthma.

Dr Monica Kraft, from the Asthma and Airway Disease Research Center, gives an overview of allergic asthma as well as walks through a patient case example of diagnosing and treating allergic asthma.

Dr Shelley Cole, from Texas Biomedical Research Institute, answers our questions about her ongoing study, "The Strong Heart Study in American Indians," and how those results impact practice.

In part 3 of his podcast series with Consultant360, Dr Robert S Laitman from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in addition to their psychiatric health.

Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.

Dr Mikhail Kosiborod discusses the cardiologist's role in treating diabetes, when a diabetes specialist should be consulted, and the overall takeaway for practicing cardiologists.

Dr Jeffrey Lackner discusses recently published results of a landmark NIH clinical trial that evaluated cognitive behavioral therapy as a method for relieving symptoms of IBS, how a gastroenterologist can approach patients who are candidates for CBT, and more.

In this podcast, Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.

Dr Jessica Bartfield from Wake Forest Baptist Health discusses intermittent fasting and time-restricted eating, what patient populations benefit most, and how the diets affect other cardiometabolic risk.

Fertility and IBD: Understanding Different Variables in Women Is Crucial by Consultant360

Schizophrenia is not a death sentence, says Dr Robert S Laitman from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery.

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the overall impact on the rheumatologist's ability to manage patients, and more.